MedPath
HSA Product

POLI-CIFLOXIN 250 TABLET 250 mg

Product approved by Health Sciences Authority (SG)

Basic Information

POLI-CIFLOXIN 250 TABLET 250 mg

TABLET, FILM COATED

Regulatory Information

SIN10308P

October 23, 1998

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 4, 2025

XJ01MA02

Company Information

POLIPHARM CO LTD

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Active Ingredients

Detailed Information

Contraindications

Contraindications: Hypersensitivity to ciprofloxacin or other quinolones. Children, adolescents, pregnancy and lactation.

Indication Information

Indications: For treatment of infections caused by sensitive to Ciprofloxacin gram positive and gram negative pathogens in respiratory tract, ear, sinuses, kidneys, urinary tract and etc.

© Copyright 2025. All Rights Reserved by MedPath